Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Dr. Carolyn Stull, board-certified dermatologist of MDCS Dermatology in New York City, described psoriasis ... Stull said ...

Psoriasis, a painful and uncomfortable inflammatory skin condition that affects millions worldwide, flares up from the ...

In addition, individuals with severe psoriasis can have an increased risk of lymphoma, like cutaneous T-cell lymphoma. Generally, treatment for psoriasis is predicated on its severity. The primary ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

Opens in a new tab or window Should you see any of these where you apply your psoriasis medication, contact your dermatologist. Is treatment that you apply to the skin right for you? For this type ...

Finding offers potential new target for treatmentPsoriasis, a painful and uncomfortable inflammatory skin condition that ...

20, 2025 — People with the skin condition psoriasis ... new research. These changes in the gut could explain why psoriasis sufferers often have ... Researchers Develop Nanofiber Patch for ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

And I remember one of them pointed with his wooden pointer at this lesion, and he says, that's psoriasis. I'm like, what the heck is psoriasis, right? So they all nodded in agreement, they walked ...

A new study published in the Archives of Dermatological Research found that patients with psoriasis who were receiving ...

Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in ...